Thiopurine methyltransferase polymorphic tandem repeat: Genotype-phenotype correlation analysis

被引:100
作者
Yan, L
Zhang, SC
Eiff, B
Szumlanski, CL
Powers, M
O'Brien, JF
Weinshilboum, RM [1 ]
机构
[1] Mayo Clin, Mayo Grad Sch, Mayo Med Sch, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA
[2] Mayo Clin, Mayo Grad Sch, Mayo Med Sch, Dept Ophthalmol, Rochester, MN 55905 USA
[3] Mayo Clin, Mayo Grad Sch, Mayo Med Sch, Dept Pathol & Lab Med, Rochester, MN 55905 USA
关键词
D O I
10.1067/mcp.2000.108674
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background. Thiopurine methyltransferase (TPMT) is a genetically polymorphic enzyme that catalyzes the S-methylation of thiopurine drugs such as 6-mercaptopurine. Recently, a variable number tandem repeat (VNTR) within the TPMT promoter has been reported to "modulate" levels of this enzyme activity. Methods: We set out to perform genotype-phenotype correlation analysis for the polymorphic TPMT tandem repeat in 1211 clinical laboratory samples in which red blood cell (RBC) TPMT activity had been measured and to compare those results with data for 279 control DNA samples. Results: TPMT VNTR length varied from three to nine repeats (*V3 to *V9), but the most common alleles were *V4 and *V5, with frequencies in the control samples of 0.54 and 0.36, respectively. The clinical laboratory samples were then stratified into those with "low," "intermediate," or "high" levels of RBC TPMT activity; that is, samples presumed to be homozygous for open reading frame (ORF)-based variant alleles, heterozygous for those alleles, or homozygous for the "wild-type" ORF sequence, respectively. TPMT VNTR genotype *V4/*V5 was associated with significantly higher RBC TPMT activity than were *V4/*V4 or *V5/*V5. Lowest activity levels were associated with genotypes that included an allele with more than 5 repeat elements. However, all of these effects were quantitatively small. Finally, there was linkage disequilibrium between VNTR allele *V5 and TPMT*3A, the most common ORF-based polymorphism associated with very low TPMT activity in white persons. Conclusions: These observations suggest that, in addition to the striking effects of ORF-based single nucleotide polymorphisms on TPMT activity, the VNTR within the 5'-flanking region of the TPMT gene also may modulate levels of RBC TPMT activity.
引用
收藏
页码:210 / 219
页数:10
相关论文
共 30 条
  • [1] de la Moureyre CSV, 1999, PHARMACOGENETICS, V9, P189
  • [2] Genotypic and phenotypic analysis of the polymorphic thiopurine S-methyltransferase gene (TPMT) in a European population
    de la Moureyre, CSV
    Debuysere, H
    Mastain, B
    Vinner, E
    Marez, D
    Lo Guidice, JM
    Chevalier, D
    Brique, S
    Motte, K
    Colombel, JF
    Turck, D
    Noel, C
    Flipo, RM
    Pol, A
    Lhermitte, M
    Lafitte, JJ
    Libersa, C
    Broly, F
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (04) : 879 - 887
  • [3] ALTERED MERCAPTOPURINE METABOLISM, TOXIC EFFECTS, AND DOSAGE REQUIREMENT IN A THIOPURINE METHYLTRANSFERASE-DEFICIENT CHILD WITH ACUTE LYMPHOCYTIC-LEUKEMIA
    EVANS, WE
    HORNER, M
    CHU, YQ
    KALWINSKY, D
    ROBERTS, WM
    [J]. JOURNAL OF PEDIATRICS, 1991, 119 (06) : 985 - 989
  • [4] HONCHEL R, 1993, MOL PHARMACOL, V43, P878
  • [5] Genetic polymorphism of thiopurine S-methyltransferase: Clinical importance and molecular mechanisms
    Krynetski, EY
    Tai, HL
    Yates, CR
    Fessing, MY
    Loennechen, T
    Schuetz, JD
    Relling, MV
    Evans, WE
    [J]. PHARMACOGENETICS, 1996, 6 (04): : 279 - 290
  • [6] A SINGLE-POINT MUTATION LEADING TO LOSS OF CATALYTIC ACTIVITY IN HUMAN THIOPURINE S-METHYLTRANSFERASE
    KRYNETSKI, EY
    SCHUETZ, JD
    GALPIN, AJ
    PUI, CH
    RELLING, MV
    EVANS, WE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (04) : 949 - 953
  • [7] CONGENITAL THIOPURINE METHYLTRANSFERASE DEFICIENCY AND 6-MERCAPTOPURINE TOXICITY DURING TREATMENT FOR ACUTE LYMPHOBLASTIC-LEUKEMIA
    LENNARD, L
    GIBSON, BES
    NICOLE, T
    LILLEYMAN, JS
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1993, 69 (05) : 577 - 579
  • [8] THIOPURINE PHARMACOGENETICS IN LEUKEMIA - CORRELATION OF ERYTHROCYTE THIOPURINE METHYLTRANSFERASE ACTIVITY AND 6-THIOGUANINE NUCLEOTIDE CONCENTRATIONS
    LENNARD, L
    VANLOON, JA
    LILLEYMAN, JS
    WEINSHILBOUM, RM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1987, 41 (01) : 18 - 25
  • [9] GENETIC-VARIATION IN RESPONSE TO 6-MERCAPTOPURINE FOR CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    LENNARD, L
    LILLEYMAN, JS
    VANLOON, J
    WEINSHILBOUM, RM
    [J]. LANCET, 1990, 336 (8709) : 225 - 229
  • [10] PHARMACOGENETICS OF ACUTE AZATHIOPRINE TOXICITY - RELATIONSHIP TO THIOPURINE METHYLTRANSFERASE GENETIC-POLYMORPHISM
    LENNARD, L
    VANLOON, JA
    WEINSHILBOUM, RM
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (02) : 149 - 154